Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access
pharmaphorum
JANUARY 21, 2022
Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry.
52 
Let's personalize your content